ScienceMed®

Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication

Medicina
Imagem de arquivo, ilustrativa — não é do estudo. Tratografia por ressonância magnética: tratos de substância branca no cérebro de um camundongo. NIH · domínio público · Wikimedia Commons

Ensaio clínico randomizadoNível 2 · Nova evidênciaBrain imaging and behavior2 nov 20236 citações

Salvar

Resumo original em inglês

O que aconteceu

The neurobiology of psychotic depression is not well understood and can be confounded by antipsychotics. Magnetic resonance spectroscopy (MRS) is an ideal tool to measure brain metabolites non-invasively. We cross-sectionally assessed brain metabolites in patients with remitted psychotic depression and controls. We also longitudinally assessed the effects of olanzapine versus placebo on brain metabolites.

Following remission, patients with psychotic depression were randomized to continue sertraline + olanzapine (n = 15) or switched to sertraline + placebo (n = 18), at which point they completed an MRS scan. Patients completed a second scan either 36 weeks later, relapse, or discontinuation. Where water-scaled metabolite levels were obtained and a Point-RESolved Spectroscopy sequence was utilized, choline, myo-inositol, glutamate + glutamine (Glx), N-acetylaspartate, and creatine were measured in the left dorsolateral prefrontal cortex (L-DLPFC) and dorsal anterior cingulate cortex (dACC). An ANCOVA was used to compare metabolites between patients (n = 40) and controls (n = 46). A linear mixed-model was used to compare olanzapine versus placebo groups.

O que encontraram

Cross-sectionally, patients (compared to controls) had higher myo-inositol (standardized mean difference [SMD] = 0.84; 95%CI = 0.25-1.44; p = 0.005) in the dACC but not different Glx, choline, N-acetylaspartate, and creatine. Longitudinally, patients randomized to placebo (compared to olanzapine) showed a significantly greater change with a reduction of creatine (SMD = 1.51; 95%CI = 0.71-2.31; p = 0.0002) in the dACC but not glutamate + glutamine, choline, myo-inositol, and N-acetylaspartate.

Por que isso importa

Patients with remitted psychotic depression have higher myo-inositol than controls. Olanzapine may maintain creatine levels. Future studies are needed to further disentangle the mechanisms of action of olanzapine.

Resumo publicado sob licença CC BY. A tradução para o português ainda não chegou a este estudo.

O estudo original

Brain metabolite levels in remitted psychotic depression with consideration of effects of antipsychotic medication

Hideaki Tani, Iska Moxon-Emre, Natalie J Forde, Nicholas H Neufeld, Kathleen S Bingham, Ellen M Whyte, Barnett S Meyers, George S Alexopoulos, Matthew J Hoptman, Anthony J Rothschild et al.

Descritores MeSH

  • Depression
  • Antipsychotic Agents
  • Brain
  • Creatine
  • Glutamine
  • Humans
  • Inositol
  • Magnetic Resonance Imaging
  • Olanzapine
  • Sertraline

Veja também